tm logo
ROMVIMZA
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 24 Apr 2024

Last Applicant/ Owned by

200 Smith Street

Waltham

US

02451

Serial Number

98238958 filed on 25th Oct 2023

Registration Number

N/A

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ROMVIMZA

Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating andRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVH), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors

Mark Details


Serial Number

No 98238958

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 062902-400

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
20th Apr 2024APPROVE OR PUB - PRINCIPAL REGISTER
12th Apr 2024TEAS RESPONSE TO OICE ACTION RECEIVE
12th Apr 2024CORRESPONENCE RECEIVE IN LAW OICE
12th Apr 2024TEAS/EMAIL CORRESPONENCE ENTERE
13th Jan 2024NOTIICATION O NON-INAL ACTION E-MAILE
13th Jan 2024NON-INAL ACTION E-MAILE
13th Jan 2024NON-INAL ACTION WRITTEN
12th Jan 2024ASSIGNE TO EXAMINER
31st Oct 2023NEW APPLICATION OICE SUPPLIE ATA ENTERE
28th Oct 2023NEW APPLICATION ENTERE